Overview

Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effect of AZD5672 (dosed to steady state) on the pharmacokinetics of digoxin (single dose administration).
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Digoxin
N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide